Quercetin

Introduction Overview

Generic Name

Quercetin

Brand Name

No specific brand name; available as various bioflavonoid complexes and extracts

Dosage Form

Oral supplements including tablets, capsules, powders, and liquid extracts

Drug Class

Flavonoid (Bioflavonoid); Dietary supplement; Antioxidant

Pharmacokinetics

Absorption: Quercetin is a flavonol commonly ingested through dietary sources such as fruits and vegetables and available as oral supplements. Upon oral administration, quercetin demonstrates variable and generally limited bioavailability due to poor water solubility and extensive first-pass metabolism. It is absorbed primarily in the small intestine via both passive diffusion and active transport mechanisms involving sodium-dependent glucose transporter 1 (SGLT1). Several studies indicate that the bioavailability can be improved when quercetin is administered as quercetin glycosides rather than the aglycone. Factors such as food matrix, co-administration with fats, and formulation of the supplement influence absorption efficiency.

Distribution: After absorption, quercetin is extensively bound to plasma proteins, primarily albumin, facilitating its transport throughout the systemic circulation. Its large volume of distribution indicates wide dispersal into tissues including the lungs, kidneys, liver, and brain. Quercetin crosses the blood-brain barrier to some extent, which may underlie some of its neuroprotective effects noted in preclinical studies. Notably, tissue accumulation patterns vary, with preferential concentration in the kidneys and lungs as observed in animal models. Distribution is impacted by quercetin’s high affinity for binding sites and potential conjugation with cellular proteins.

Metabolism: Quercetin undergoes extensive phase II metabolism predominantly in the enterocytes and hepatocytes. Conjugation reactions include glucuronidation, sulfation, and methylation mediated by UDP-glucuronosyltransferases (UGTs), sulfotransferases, and catechol-O-methyltransferases (COMT), respectively. These metabolites, such as quercetin-3-glucuronide and isorhamnetin, are the primary circulating forms rather than the aglycone. This metabolism reduces the parent compound’s plasma half-life but may contribute to the compound’s systemic antioxidant activity. Gut microbiota also metabolize unmetabolized quercetin into smaller phenolic acids, which further influence bioactivity and systemic effects.

Elimination: Quercetin and its metabolites are eliminated predominantly via renal and biliary excretion. Renal clearance involves filtration and active tubular secretion of conjugated metabolites, while biliary excretion leads to enterohepatic recycling contributing to prolonged systemic presence. The elimination half-life of quercetin metabolites varies between 11 to 28 hours depending on the metabolite profile and individual patient factors. Renal and hepatic function significantly influence elimination kinetics, and impaired organ function may alter systemic exposure. Overall, quercetin demonstrates complex pharmacokinetics characterized by limited bioavailability balanced by extensive metabolism and recycling.

Dosage Forms

Available Dosage Forms: Quercetin is commonly available in various oral formulations including:
- Oral capsules (e.g., typical doses ranging from 250 mg to 500 mg per capsule)
- Oral tablets with standardized quercetin content
- Powders and bulk extracts intended for mixing into liquids or food
- Liquid oral extracts and tinctures with varying concentrations

Dosages for Adults and Adolescents: Standard supplement dosages generally range from 250 mg to 1000 mg daily, typically divided into two or three doses. Clinical trials exploring cardiovascular and exercise capacity benefits have used doses in this range. There is no established therapeutic dose for specific diseases as quercetin is classified as a dietary supplement. Dosing may be adjusted based on product formulation, patient tolerance, and concurrent therapies.

Specific Patient Populations: In patients with cardiovascular disease or hypertension, quercetin supplementation may be initiated cautiously with medical supervision, especially if the patient is on other vasomodulatory or anticoagulant medications. There is limited evidence on pediatric dosing, and safety has not been established in pregnant or breastfeeding women; thus, use is not recommended in these populations. In patients with renal or hepatic impairment, monitoring for adverse effects is prudent due to altered metabolism and clearance.

Mechanism Of Action

Quercetin is a polyphenolic flavonoid that exerts multiple biochemical and cellular effects predominantly through its potent antioxidant properties. The principal mechanism involves scavenging reactive oxygen species (ROS) and reactive nitrogen species (RNS), thereby reducing oxidative stress at the cellular and vascular level. Quercetin donates electrons to neutralize free radicals and inhibits lipid peroxidation within cellular membranes, which helps preserve cell integrity and function.

Beyond its antioxidant activity, quercetin modulates various signaling pathways involved in inflammation and vascular homeostasis. It inhibits key pro-inflammatory enzymes such as cyclooxygenase (COX) and lipoxygenase (LOX), resulting in decreased synthesis of pro-inflammatory mediators like prostaglandins and leukotrienes. Quercetin also downregulates nuclear factor kappa B (NF-κB) activation, a critical transcription factor regulating inflammatory cytokines, adhesion molecules, and enzymes involved in immune responses. These effects combined contribute to its anti-inflammatory potential in vascular tissues and other organs.

Quercetin influences endothelial function by enhancing nitric oxide (NO) bioavailability through endothelial nitric oxide synthase (eNOS) activation and reducing oxidative degradation of NO. This vasodilatory action contributes to improved blood flow and may underlie quercetin's observed blood pressure lowering effects in clinical studies. Additionally, quercetin modulates the activity of various ion channels and transporters, which can influence vascular tone and muscular function.

Comparatively, quercetin shares some mechanisms with other flavonoids and antioxidant compounds but distinguishes itself by the breadth of targets including kinase enzymes (e.g., MAPK pathways), mitochondrial function modulation, and epigenetic regulation. Emerging research also suggests quercetin’s ability to modulate cellular senescence and apoptosis processes, which may have implications in cardiovascular and neuroprotection therapies. Clinical trials continue to explore quercetin's multifunctional profile in cardiovascular health, exercise performance, and anti-inflammatory applications.

Pharmacological Actions

Potent antioxidant activity through scavenging free radicals and reducing oxidative stress
Anti-inflammatory effects via inhibition of COX, LOX, and NF-κB signaling pathways
Endothelial function improvement by enhancing nitric oxide bioavailability and vasodilation
Modulation of cellular signaling pathways including MAPK and apoptotic pathways
Potential antihypertensive effects through vascular smooth muscle relaxation
Antiviral and immunomodulatory properties demonstrated in preclinical studies
Reduction of lipid peroxidation and protection against atherosclerotic changes
Neuroprotective effects due to blood-brain barrier penetration and oxidative damage mitigation
Inhibition of pro-inflammatory cytokine production such as TNF-alpha and IL-6
Stabilization of mast cells reducing allergic responses
Inhibition of platelet aggregation indicating possible antithrombotic effects
Modulation of mitochondrial function to enhance cellular energy metabolism
Potential anti-cancer activity via modulation of cell cycle and apoptosis

Therapeutic Or Clinical Uses

Adjunctive support in hypertension to help lower blood pressure
Cardiovascular protection by improving endothelial function and reducing oxidative damage
Enhancement of exercise performance and endurance capacity in some individuals
Alleviation of inflammation associated with chronic diseases such as arthritis
Potential adjunctive use in viral infections due to immunomodulatory effects
Support for allergy symptom management due to mast cell stabilization
Reduction of oxidative stress-related complications in metabolic syndrome
Neuroprotection against oxidative stress in neurodegenerative conditions
Supportive therapy in atherosclerosis by limiting LDL oxidation
Possible protective effects in cancer adjunctive therapy via apoptosis induction
Management of chronic inflammation in conditions like asthma and COPD
Skin protection from UV-induced damage and photoaging
Adjunct in managing blood sugar and insulin resistance in diabetes mellitus
Supportive role in liver health through antioxidant mechanisms
General health supplement with antioxidant and anti-inflammatory properties

Side Or Adverse Effects

Upset stomach including mild gastrointestinal discomfort or nausea
Potential allergic reactions such as rash or itching in sensitive individuals
Headache reported occasionally with higher doses
Rare reports of dizziness or mild hypotension
Interactions leading to altered blood thinning effects particularly with warfarin
Possible interference with the absorption or effectiveness of certain drugs such as digoxin
Photosensitivity reactions reported rarely with prolonged exposure
No significant toxicities reported at standard supplement doses
Potential for mild headache or fatigue in some users
Gastrointestinal disturbances such as bloating or diarrhea at high doses
Rare hypersensitivity reactions including skin swelling or breathlessness
Caution advised due to lack of extensive safety data in pregnancy and breastfeeding
Extremely rare cases of muscle pain or weakness noted anecdotally
Potential alteration of thyroid hormone metabolism in theoretical models
Mild bleeding risk augmentation when combined with anticoagulants

Precautions

Consult physician prior to use especially if taking prescription medications or other supplements
Avoid concurrent use with digoxin due to potential drug interaction
Monitor closely if using blood-thinning agents such as warfarin owing to increased bleeding risk
Not recommended during breastfeeding due to insufficient safety data
Exercise caution and medical oversight if pregnant or planning pregnancy
Use cautiously in patients with existing heart conditions or high blood pressure
Potential interactions with immunosuppressive and chemotherapeutic agents
Discontinue use and seek medical attention if signs of allergic reaction occur
Assess intake carefully in individuals with autoimmune disorders
May affect hormone metabolism; caution in endocrine disorders advised
Avoid if known hypersensitivity to flavonoids or related compounds
Inform healthcare provider of all natural products and medications being taken
Use with caution in hepatic or renal impairment due to altered metabolism
Avoid excessive doses beyond recommended supplement levels
Monitor for gastrointestinal symptoms and adjust dosage accordingly

Warnings

Seek emergency medical attention if experiencing severe allergic reaction symptoms such as wheezing, chest tightness, swelling of face or throat
Risk of bleeding may be increased when combined with anticoagulant or antiplatelet medications
Not approved for treatment of any disease; intended as a dietary supplement
Avoid use during breastfeeding due to unknown effects on the infant
Potential for interactions with cardiac glycosides such as digoxin
Use under medical supervision if underlying cardiovascular or hypertensive conditions exist
Do not exceed the manufacturer’s recommended dose
Discontinue use if severe gastrointestinal symptoms develop
Potential photosensitivity warranting protection from extensive sun exposure
Monitor for any neurological symptoms including headache or dizziness
Not studied extensively in children; use only if advised by a healthcare provider
Possible interference with drug metabolism enzymes has theoretical impact
Avoid in individuals with known allergy to quercetin or citrus bioflavonoids
Long-term safety data is limited; regular evaluation recommended
Avoid combining with other supplements or medications without professional guidance

Contraindication

Known hypersensitivity or allergy to quercetin or related flavonoids
Concurrent use with digoxin due to potential for adverse drug interactions
Breastfeeding mothers should avoid use owing to insufficient safety data
Patients with bleeding disorders or those on anticoagulant therapy without medical supervision
Severe hepatic or renal impairment due to altered metabolism and clearance
Use contraindicated in individuals with hypersensitivity to citrus-derived bioflavonoids
Children and adolescents unless specifically directed by a physician
In combination with other potent anticoagulants without close medical monitoring
Patients undergoing immunosuppressive therapy where immune modulation is contraindicated
Contraindicated in individuals with active severe allergic reactions to similar compounds
Those with known seizure disorders should use cautiously pending further safety evaluation
Avoid use in individuals with uncontrolled hypertension until evaluated by healthcare provider
Contraindicated in pregnancy unless benefits clearly outweigh risks as determined by physician
Not recommended in acute inflammatory or infectious conditions without medical advice
Incompatible with certain chemotherapeutic agents; consult oncologist before use

Drug Interactions

May potentiate effects of anticoagulants such as warfarin leading to increased bleeding risk
Interaction with digoxin may alter plasma levels and efficacy of digoxin
Potential induction or inhibition of cytochrome P450 enzymes affecting metabolism of concurrent drugs
Possible pharmacodynamic interaction with antiplatelet agents increasing bleeding tendency
Co-administration with immunosuppressive drugs may alter immune response
May influence absorption of certain antibiotics or chemotherapeutic agents
Could interfere with thyroid hormone replacement therapy through metabolic interactions
Interaction with nonsteroidal anti-inflammatory drugs (NSAIDs) potentially altering efficacy
May affect bioavailability of drugs metabolized by UGT and COMT enzymes
Possible additive hypotensive effects with antihypertensive medications
Concurrent use with corticosteroids requires monitoring for potential modulation of effects
Interaction with digoxin necessitates avoidance due to safety concerns
May impact drugs that require specific antioxidant balance such as chemotherapy
Potential interference with drugs sensitive to antioxidant status and oxidative enzymes
Avoid combination with other flavonoid-containing herbal supplements to prevent additive interactions

Preparations Of The Drug

Standardized quercetin capsules ranging from 250 mg to 500 mg per unit
Powdered quercetin extracts intended for mixing with liquids
Liquid quercetin extracts and tinctures for enhanced bioavailability
Complex formulations combining quercetin with vitamin C or bromelain to improve absorption
Bioflavonoid concentrates and citrus bioflavonoid extracts featuring quercetin
Topical formulations containing quercetin for skin photoprotection (less common)
Formulations with quercetin dihydrate to enhance stability
Nutritional supplements blending quercetin with other flavonoids for synergistic effects
Pharmaceutical-grade quercetin preparations for clinical research use
Capsules combining quercetin with antioxidants such as resveratrol or green tea extract
Powders standardized to quercetin content for precise dosing in clinical trials
Tablet formulations combining bioflavonoids targeting inflammatory and cardiovascular health
Oral liquids formulated with solubilizing agents to improve quercetin bioavailability
Dietary supplement blends marketed for cardiovascular and exercise capacity support
Natural-source extracts containing quercetin alongside other polyphenols